Drug and Medication Analysis & Statistics in France, June 2013 (p3)

61-71 of 71 reports

Purchase Reports From Reputable Market Research Publishers

2013 Endocrine Function Testing Market in France: Hospitals and Commercial Labs

2013 Endocrine Function Testing Market in France: Hospitals and Commercial Labs

  • $ 2 450
  • Industry report
  • June 2013
  • by Venture Planning Group

This new 269-page report from Venture Planning Group provides a comprehensive analysis in the French endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts ...

  • Industries : Drug and Medication
  • Countries : France
2013 Therapeutic Drug Monitoring (TDM) Market in France: Hospitals and Commercial Labs

2013 Therapeutic Drug Monitoring (TDM) Market in France: Hospitals and Commercial Labs

  • $ 2 450
  • Industry report
  • June 2013
  • by Venture Planning Group

This new 247-page report from Venture Planning Group provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Drug and Medication
  • Countries : France
PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : France
PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • February 2013
  • by Global Data

PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis ...

  • Industries : Pathology, Drug and Medication
  • Countries : France
PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • February 2013
  • by Global Data

PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022”. ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Drug and Medication
  • Countries : France
PharmaPoint: HIV - France Drug Forecast and Market Analysis to 2022

PharmaPoint: HIV - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • January 2013
  • by Global Data

PharmaPoint: HIV - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: HIV - France Drug Forecast and Market Analysis to 2022”. Human ...

  • Industries : Drug and Medication, Pathology
  • Countries : France
Quad 2 (HIV) - Forecast and Market Analysis to 2022

Quad 2 (HIV) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2013
  • by Global Data

Quad 2 (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Quad 2 (HIV) - Forecast and Market Analysis to 2022”. Human Immunodeficiency ...

  • Industries : Pathology, Drug and Medication
  • Countries : France, Germany, Italy, Spain, United Kingdom, Japan, Brazil, China
2013 French Hospital Infectious Disease Testing Market

2013 French Hospital Infectious Disease Testing Market

  • $ 2 900
  • Industry report
  • December 2012
  • by Venture Planning Group

This new report from Venture Planning Group contains 897 pages, 77 tables, and presents a comprehensive analysis of the French hospital infectious disease testing market, including: - Major issues pertaining ...

  • Industries : Drug and Medication
  • Countries : France
Future Horizons in the French Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment

Future Horizons in the French Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment

  • $ 5 900
  • Industry report
  • August 2012
  • by Venture Planning Group

Highlights Comprehensive 850-page market segmentation analysis of the French NAT market.Major issues pertaining to the French NAT laboratory practice, as well as key economic, regulatory, demographic, ...

  • Industries : Drug and Medication
  • Countries : France
The 2012 French Molecular Diagnostics Market

The 2012 French Molecular Diagnostics Market

  • $ 5 900
  • Industry report
  • March 2012
  • by Venture Planning Group

This report presents a comprehensive analysis of the French molecular diagnostics market, including:Major issues pertaining to the French molecular diagnostics laboratory practice, as well as key economic, ...

  • Industries : Drug and Medication, Pathology
  • Countries : France
French Nucleic Acid Testing Market

French Nucleic Acid Testing Market

  • $ 5 900
  • Industry report
  • August 2011
  • by Venture Planning Group

Highlights Comprehensive 850-page market segmentation analysis of the French NAT market.Major issues pertaining to the French NAT laboratory practice, as well as key economic, regulatory, demographic, ...

  • Industries : Drug and Medication
  • Countries : France
About 200 reports

Download Unlimited Documents from Trusted Public Sources

Methotrexate Markets in France

  • February 2015
    4 pages
  • Methotrexate  

  • France  

View report >

Drug Industry - Forecast

December 2014

Drug Industry In France

November 2014

Pathology Description

August 2014

Economic Analysis

August 2014

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.